Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Read the official notice →- Date
- 2024-05-29
- Country
- United States
- Brand
- Preferred Pharmaceuticals
- Product
- Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
- Classification
- Class II
- Units
- Product distributed to CA, FL, OK, KS and CT
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Preferred Pharmaceuticals recalls
- 2025-12-24
USPreferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred…
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished…
- 2025-05-07
- US
- 2024-09-04
- US
Preferred Pharmaceuticals, Inc. recalls Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana,…
Failed Impurities/Degradation Specifications - at 18-month Stability testing
- 2023-07-12
- US
- 2023-04-12
- US
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-7149-1
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
- US
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge…
CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.
Other drugs & medical recalls in the United States
- 2024-05-29
- US
Hikma Injectables USA Inc recalls Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36…
Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
- US
American Regent, Inc. recalls Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American…
Subpotent product in addition to having out-of-specification results for impurities.
- US
SOMERSET THERAPEUTICS LLC recalls Haloperidol decanoate Injection 50mg/mL, packaged in a) 1 mL Single-Dose Vials (NDC 70069-381-01) and b) 10 1mL Single-Dose Vials (NDC…
Presence of Foreign Substance: This oil based product may contain trace amounts of water for injection (WFI).
- US
Dr. Reddy's Laboratories, Inc. recalls Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made…
Failed Impurities/Degradation Specifications
- US
- US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical…
Failed Release Testing: Out of specification for particulate matter test.